ODDB.org: Open Drug Database

Home - 66172

Swissmedic Registration	66172	Date of registration	20.10.2017
Company name	Basilea Pharmaceutica International AG, Allschwil	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	08.06.	Revocation Date
Index Therapeuticus (Swissmedic)	08.06.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Cresemba 100 mg	Hartkapseln	Capsules (Isavuconazonium 100 mg)	J02AC05	CI
02	Cresemba 40 mg	Hartkapseln	Capsules (Isavuconazonium 40 mg)	J02AC05

2025	©ywesee GmbH